Clinical Trial Update: Efficacy and Safety Study of Autologous Hematopoietic Stem Cell Transplantation to Treat New Onset Type 1 Diabetes [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating autologous hematopoietic stem cell transplantation for new-onset Type 1 diabetes, reporting efficacy and safety results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Autologous hematopoietic stem cell transplantation (Autologous hematopoietic stem cell transplantation)

Snippet

Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | Conditions: Type 1 Diabetes | Phase 2 | Status: COMPLETED